MEDIFAST INCMEDEarnings & Financial Report
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
MED Q4 FY2025 Key Financial Metrics
Revenue
$75.1M
Gross Profit
$52.1M
Operating Profit
$-7.8M
Net Profit
N/A
Gross Margin
69.4%
Operating Margin
-10.4%
Net Margin
N/A
YoY Growth
-36.9%
EPS
$-1.64
MEDIFAST INC Q4 FY2025 Financial Summary
MEDIFAST INC reported revenue of $75.1M (down 36.9% YoY) for Q4 FY2025, with a net profit of N/A (N/A margin). Cost of goods sold was $23.0M, operating expenses totaled $59.9M.
Key Financial Metrics
| Total Revenue | $75.1M |
|---|---|
| Net Profit | N/A |
| Gross Margin | 69.4% |
| Operating Margin | -10.4% |
| Report Period | Q4 FY2025 |
MEDIFAST INC Annual Revenue by Year
MEDIFAST INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $385.8M).
MEDIFAST INC Quarterly Revenue & Net Profit History
MEDIFAST INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $75.1M | -36.9% | N/A | N/A |
| Q3 FY2025 | $89.4M | -36.2% | $-2.3M | -2.5% |
| Q2 FY2025 | $105.6M | -37.4% | $2.5M | 2.3% |
| Q1 FY2025 | $115.7M | -33.8% | $-772.0K | -0.7% |
| Q4 FY2024 | $119.0M | -37.7% | N/A | N/A |
| Q3 FY2024 | $140.2M | -40.6% | $1.1M | 0.8% |
| Q2 FY2024 | $168.6M | -43.1% | $-8.2M | -4.8% |
| Q1 FY2024 | $174.7M | -49.9% | $8.3M | 4.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $174.7M | $168.6M | $140.2M | $119.0M | $115.7M | $105.6M | $89.4M | $75.1M |
| YoY Growth | -49.9% | -43.1% | -40.6% | -37.7% | -33.8% | -37.4% | -36.2% | -36.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $302.8M | $293.5M | $291.2M | $284.2M | $280.0M | $269.3M | $268.2M | $248.0M |
| Liabilities | $91.8M | $88.2M | $83.9M | $74.1M | $69.1M | $53.3M | $53.5M | $49.1M |
| Equity | $211.0M | $205.3M | $207.3M | $210.1M | $211.0M | $216.0M | $214.7M | $198.9M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $7.3M | $13.1M | $9.1M | $-4.9M | $3.4M | $-3.4M | $12.1M | $-5.3M |